These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 15030392)

  • 1. Protection against glucose-induced neuronal death by NAAG and GCP II inhibition is regulated by mGluR3.
    Berent-Spillson A; Robinson AM; Golovoy D; Slusher B; Rojas C; Russell JW
    J Neurochem; 2004 Apr; 89(1):90-9. PubMed ID: 15030392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GCP II inhibition rescues neurons from gp120IIIB-induced neurotoxicity.
    Thomas AG; Bodner A; Ghadge G; Roos RP; Slusher BS
    J Neurovirol; 2009 Sep; 15(5-6):449-57. PubMed ID: 19995130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroprotection afforded by NAAG and NAALADase inhibition requires glial cells and metabotropic glutamate receptor activation.
    Thomas AG; Olkowski JL; Slusher BS
    Eur J Pharmacol; 2001 Aug; 426(1-2):35-8. PubMed ID: 11525768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabotropic glutamate receptor 3 protects neurons from glucose-induced oxidative injury by increasing intracellular glutathione concentration.
    Berent-Spillson A; Russell JW
    J Neurochem; 2007 Apr; 101(2):342-54. PubMed ID: 17402968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabotropic glutamate receptor regulation of neuronal cell death.
    Spillson AB; Russell JW
    Exp Neurol; 2003 Nov; 184 Suppl 1():S97-105. PubMed ID: 14597332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of NAAG peptidase inhibitor 2-PMPA in model chronic pain - relation to brain concentration.
    Nagel J; Belozertseva I; Greco S; Kashkin V; Malyshkin A; Jirgensons A; Shekunova E; Eilbacher B; Bespalov A; Danysz W
    Neuropharmacology; 2006 Dec; 51(7-8):1163-71. PubMed ID: 16926034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of NAALADase by 2-PMPA attenuates cocaine-induced relapse in rats: a NAAG-mGluR2/3-mediated mechanism.
    Xi ZX; Li X; Peng XQ; Li J; Chun L; Gardner EL; Thomas AG; Slusher BS; Ashby CR
    J Neurochem; 2010 Jan; 112(2):564-76. PubMed ID: 19895667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glutamate carboxypeptidase II (GCPII) inhibitor 2-PMPA reduces rewarding effects of the synthetic cathinone MDPV in rats: a role for N-acetylaspartylglutamate (NAAG).
    Hicks C; Gregg RA; Nayak SU; Cannella LA; Schena GJ; Tallarida CS; Reitz AB; Smith GR; Rawls SM
    Psychopharmacology (Berl); 2017 Jun; 234(11):1671-1681. PubMed ID: 28251297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of glutamate carboxypeptidase II (NAALADase) protects against dynorphin A-induced ischemic spinal cord injury in rats.
    Long JB; Yourick DL; Slusher BS; Robinson MB; Meyerhoff JL
    Eur J Pharmacol; 2005 Jan; 508(1-3):115-22. PubMed ID: 15680261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-acetyl-aspartyl-glutamate and inhibition of glutamate carboxypeptidases protects against soman-induced neuropathology.
    Guo H; Liu J; Van Shura K; Chen H; Flora MN; Myers TM; McDonough JH; McCabe JT
    Neurotoxicology; 2015 May; 48():180-91. PubMed ID: 25825357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Local administration of N-acetylaspartylglutamate (NAAG) peptidase inhibitors is analgesic in peripheral pain in rats.
    Yamamoto T; Saito O; Aoe T; Bartolozzi A; Sarva J; Zhou J; Kozikowski A; Wroblewska B; Bzdega T; Neale JH
    Eur J Neurosci; 2007 Jan; 25(1):147-58. PubMed ID: 17241276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroprotective effects of N-acetylaspartylglutamate in a neonatal rat model of hypoxia-ischemia.
    Cai Z; Lin S; Rhodes PG
    Eur J Pharmacol; 2002 Feb; 437(3):139-45. PubMed ID: 11890901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of GCP-II inhibition on responses of dorsal horn neurones after inflammation and neuropathy: an electrophysiological study in the rat.
    Carpenter KJ; Sen S; Matthews EA; Flatters SL; Wozniak KM; Slusher BS; Dickenson AH
    Neuropeptides; 2003 Oct; 37(5):298-306. PubMed ID: 14607107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NAAG Peptidase Inhibitors Act via mGluR3: Animal Models of Memory, Alzheimer's, and Ethanol Intoxication.
    Olszewski RT; Janczura KJ; Bzdega T; Der EK; Venzor F; O'Rourke B; Hark TJ; Craddock KE; Balasubramanian S; Moussa C; Neale JH
    Neurochem Res; 2017 Sep; 42(9):2646-2657. PubMed ID: 28285415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NAAG peptidase inhibitors block cognitive deficit induced by MK-801 and motor activation induced by d-amphetamine in animal models of schizophrenia.
    Olszewski RT; Janczura KJ; Ball SR; Madore JC; Lavin KM; Lee JC; Lee MJ; Der EK; Hark TJ; Farago PR; Profaci CP; Bzdega T; Neale JH
    Transl Psychiatry; 2012 Jul; 2(7):e145. PubMed ID: 22850437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroprotection mediated by glutamate carboxypeptidase II (NAALADase) inhibition requires TGF-beta.
    Thomas AG; Liu W; Olkowski JL; Tang Z; Lin Q; Lu XC; Slusher BS
    Eur J Pharmacol; 2001 Oct; 430(1):33-40. PubMed ID: 11698060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of glutamate carboxypeptidase II hydrolysis of N-acetylaspartylglutamate (NAAG) in crayfish nervous tissue is mediated by glial glutamate and acetylcholine receptors.
    Urazaev AK; Grossfeld RM; Lieberman EM
    J Neurochem; 2005 May; 93(3):605-10. PubMed ID: 15836619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroprotection produced by the NAALADase inhibitor 2-PMPA in rat cerebellar neurons.
    Tortella FC; Lin Y; Ved H; Slusher BS; Dave JR
    Eur J Pharmacol; 2000 Aug; 402(1-2):31-7. PubMed ID: 10940354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NAAG inhibits KCl-induced [(3)H]-GABA release via mGluR3, cAMP, PKA and L-type calcium conductance.
    Zhao J; Ramadan E; Cappiello M; Wroblewska B; Bzdega T; Neale JH
    Eur J Neurosci; 2001 Jan; 13(2):340-6. PubMed ID: 11168538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioanalytical method for evaluating the pharmacokinetics of the GCP-II inhibitor 2-phosphonomethyl pentanedioic acid (2-PMPA).
    Rais R; Rojas C; Wozniak K; Wu Y; Zhao M; Tsukamoto T; Rudek MA; Slusher BS
    J Pharm Biomed Anal; 2014 Jan; 88():162-9. PubMed ID: 24055700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.